Although the abundance of E-cadherin and claudin-3 proteins has been studied indifferent clinical and experimental situations, to the best of our knowledge, theirtissue abundance has not yet been measured in experimental DC models of animalstreated with infliximab. The gene discussed is CDH1; the disease is dyskeratosis congenita.